Zacks: Brokerages Anticipate RadNet Inc. (RDNT) to Post $0.13 Earnings Per Share
Analysts predict that RadNet Inc. (NASDAQ:RDNT) will announce $0.13 earnings per share (EPS) for the current quarter, Zacks reports. Two analysts have made estimates for RadNet’s earnings, with estimates ranging from $0.12 to $0.13. RadNet posted earnings per share of $0.11 in the same quarter last year, which would indicate a positive year-over-year growth rate of 18.2%. The firm is expected to announce its next earnings report on Tuesday, August 14th.
On average, analysts expect that RadNet will report full year earnings of $0.37 per share for the current fiscal year, with EPS estimates ranging from $0.36 to $0.37. For the next financial year, analysts forecast that the business will report earnings of $0.62 per share, with EPS estimates ranging from $0.57 to $0.67. Zacks’ EPS averages are a mean average based on a survey of sell-side research analysts that that provide coverage for RadNet.
RadNet (NASDAQ:RDNT) last announced its quarterly earnings results on Wednesday, May 9th. The medical research company reported ($0.15) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.04 by ($0.19). RadNet had a negative net margin of 0.66% and a positive return on equity of 18.77%. The company had revenue of $231.39 million for the quarter, compared to the consensus estimate of $234.32 million. During the same quarter in the prior year, the company earned ($0.03) earnings per share. The company’s quarterly revenue was up 1.0% on a year-over-year basis.
In other RadNet news, VP Mark Stolper sold 15,000 shares of the stock in a transaction that occurred on Tuesday, March 20th. The shares were sold at an average price of $13.19, for a total transaction of $197,850.00. Following the transaction, the vice president now directly owns 130,319 shares in the company, valued at $1,718,907.61. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Jeffrey L. Linden sold 10,000 shares of the stock in a transaction that occurred on Wednesday, March 14th. The shares were sold at an average price of $13.09, for a total transaction of $130,900.00. Following the transaction, the insider now owns 922,001 shares in the company, valued at $12,068,993.09. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 138,927 shares of company stock worth $1,796,452. 7.56% of the stock is owned by company insiders.
A number of hedge funds and other institutional investors have recently modified their holdings of the business. Financial Gravity Wealth Inc. bought a new position in RadNet during the first quarter valued at approximately $759,000. Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp grew its position in RadNet by 11.8% during the first quarter. Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp now owns 66,200 shares of the medical research company’s stock valued at $953,000 after acquiring an additional 7,000 shares during the last quarter. Adalta Capital Management LLC bought a new position in RadNet during the first quarter valued at approximately $175,000. Millennium Management LLC grew its position in RadNet by 927.5% during the first quarter. Millennium Management LLC now owns 295,806 shares of the medical research company’s stock valued at $4,260,000 after acquiring an additional 267,016 shares during the last quarter. Finally, Guggenheim Capital LLC grew its position in RadNet by 696.1% during the first quarter. Guggenheim Capital LLC now owns 102,581 shares of the medical research company’s stock valued at $1,477,000 after acquiring an additional 89,695 shares during the last quarter. Institutional investors and hedge funds own 57.84% of the company’s stock.
Shares of RDNT opened at $12.95 on Thursday. RadNet has a twelve month low of $7.01 and a twelve month high of $14.85. The stock has a market cap of $624.71 million, a PE ratio of 40.47, a P/E/G ratio of 4.43 and a beta of 0.42. The company has a current ratio of 1.12, a quick ratio of 1.12 and a debt-to-equity ratio of 4.90.
RadNet, Inc, together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for RadNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RadNet and related companies with MarketBeat.com's FREE daily email newsletter.